Episode Details

Back to Episodes

Paul Jaminet on Pioneering Cancer Therapies & Leadership in Biotech

Published 1 year, 9 months ago
Description

Send us Fan Mail

In this episode of Life Science Success, we sit down with Paul Jaminet, Ph.D., founder and CEO of Angiex, Inc., to explore his groundbreaking work in developing Nuclear-Delivered Antibody-Drug Conjugates™ for cancer therapy. Paul shares his unique career journey from astrophysics to biotech, insights into leading innovative projects, and the challenges and triumphs of pushing the boundaries in cancer treatment. Don't miss this inspiring conversation with a visionary leader in the life sciences.

🔗 Learn more about Angiex, Inc.: https://angiex.com/ 📚 Discover Paul's book, "Perfect Health Diet": https://www.amazon.com/Perfect-Health... 🎙️ Subscribe for more insights from top industry leaders!

 

In this episode of Life Science Success, host Don interviews Paul Jaminet, founder and CEO of Angenex. Paul shares his unique journey from astrophysics to life sciences, detailing his groundbreaking work in developing nuclear delivered antibody drug conjugates targeting angiogenic tumor vasculature. Learn about the challenges, motivations, and scientific discoveries driving Angenex's success.
 
Sponsored by D3 Digital Media Marketing.
 
 
00:00 Introduction to Life Science Success Podcast
00:41 Sponsor Message from D3 Digital Media Marketing
01:23 Interview with Paul Jaminet: Founder and CEO of Angenex
01:45 Paul Jaminet's Journey from Astrophysics to Life Sciences
04:35 The Birth of Angenex and Its Groundbreaking Work
06:34 Challenges and Innovations in Developing Antibody Drug Conjugates
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us